Pathologic Effects of Neoadjuvant Radiation Therapy in Operable Early Stage Lung Cancer
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
pathological effects of hypofractionated radiation therapy
To describe the pathological effects of hypofractionated radioation therapy (RT) and to address the relationship with blood and tissue biomarkers and bio-imaging.
at 2 years
Jan Van Meerbeeck, MD, PhD
University Hospital Ghent, Belgium
Belgium: Ethics Committee